Literature DB >> 9709179

Renal haemodynamic characteristics in patients with lupus nephritis.

M Nakano1, M Ueno, H Hasegawa, T Watanabe, T Kuroda, S Ito, M Arakawa.   

Abstract

OBJECTIVE: To clarify the characteristics of renal haemodynamics in patients with lupus nephritis (LN).
METHODS: The glomerular filtration rate (GFR) and renal plasma flow (RPF) of 37 patients with active LN were studied longitudinally over an interval of 8 to 144 weeks during treatment with corticosteroids or cytotoxic drugs, or both. All patients had clinical renal disorders and underwent renal biopsies.
RESULTS: Analysis of renal biopsy specimens showed that 31 patients had class IV LN. Class II, III, and VLN were present in two patients each. The average GFR increased significantly from 65.4 (SD 33.0) in the pretreatment stage to 86.6 (31.6) ml/min in the post-treatment stage, accompanied by an improvement in urinary or immunological abnormalities, or both. On the other hand, RPF decreased significantly from 625.2 (243.0) to 519.8 (179.0) ml/min. Therefore, the filtration fraction (FF) increased significantly from 10.7 (4.3)% to 16.8 (3.7)%. Low FF was recognised predominantly in patients with class IV LN, but was also observed in patients with other classes. The FF returned towards normal irrespective of the degree of GFR recovery. No significant changes were observed in the levels of blood pressure.
CONCLUSION: A reduction in GFR out of proportion to the reduction in RPF as demonstrated by the low FF values was related to the severity of LN or disease activity, or both. Therefore, relative evaluation of GFR and RPF, namely the determination of FF, may be a useful clinical parameter to determine the status of LN.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9709179      PMCID: PMC1752569          DOI: 10.1136/ard.57.4.226

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

1.  Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy.

Authors:  S Björck; G Nyberg; H Mulec; G Granerus; H Herlitz; M Aurell
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

2.  Immune complex effects on glomerular eicosanoid production and renal hemodynamics.

Authors:  M A Rahman; S N Emancipator; M J Dunn
Journal:  Kidney Int       Date:  1987-06       Impact factor: 10.612

3.  Prognostic factors in diffuse proliferative lupus glomerulonephritis.

Authors:  A B Magil; M L Puterman; H S Ballon; V Chan; D S Lirenman; A Rae; R A Sutton
Journal:  Kidney Int       Date:  1988-10       Impact factor: 10.612

4.  Renal effects of indomethacin in patients with systemic lupus erythematosus.

Authors:  E J ter Borg; P E de Jong; S Meijer; C G Kallenberg
Journal:  Nephron       Date:  1989       Impact factor: 2.847

Review 5.  Antibodies to DNA in patients with systemic lupus erythematosus. Their role in the diagnosis, the follow-up and the pathogenesis of the disease.

Authors:  R Smeenk; K Brinkman; H van den Brink; R M Termaat; J Berden; H Nossent; T Swaak
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

6.  Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.

Authors:  M Marre; G Chatellier; H Leblanc; T T Guyene; J Menard; P Passa
Journal:  BMJ       Date:  1988-10-29

7.  Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients.

Authors:  H C Nossent; S C Henzen-Logmans; T M Vroom; J H Berden; T J Swaak
Journal:  Arthritis Rheum       Date:  1990-07

8.  Effect of long-term normalization of serum complement levels on the course of lupus nephritis.

Authors:  R S Laitman; D Glicklich; L B Sablay; A I Grayzel; P Barland; N Bank
Journal:  Am J Med       Date:  1989-08       Impact factor: 4.965

9.  Serial assessment of glomerular filtration rate in lupus nephropathy.

Authors:  M Petri; L Bockenstedt; J Colman; Q Whiting-O'Keefe; G Fitz; A Sebastian; D Hellmann
Journal:  Kidney Int       Date:  1988-12       Impact factor: 10.612

10.  Clinical outcome of three discrete histologic patterns of injury in severe lupus glomerulonephritis.

Authors:  M M Schwartz; S P Lan; S M Bonsib; G N Gephardt; H M Sharma
Journal:  Am J Kidney Dis       Date:  1989-04       Impact factor: 8.860

View more
  13 in total

Review 1.  Understanding mechanisms of hypertension in systemic lupus erythematosus.

Authors:  Erin B Taylor; Michael J Ryan
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-03-15

2.  Persistent hypertension in lupus nephritis and the associated risk factors.

Authors:  Syahrul Syazliana Shaharir; Ruslinda Mustafar; Rozita Mohd; Mohd Shahrir Mohd Said; Halim A Gafor
Journal:  Clin Rheumatol       Date:  2014-11-06       Impact factor: 2.980

3.  Blood pressure and renal hemodynamic responses to acute angiotensin II infusion are enhanced in a female mouse model of systemic lupus erythematosus.

Authors:  Marcia Venegas-Pont; Keisa W Mathis; Radu Iliescu; William H Ray; Porter H Glover; Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-07       Impact factor: 3.619

Review 4.  Autoimmune-mediated renal disease and hypertension.

Authors:  Erika I Boesen; Rahul M Kakalij
Journal:  Clin Sci (Lond)       Date:  2021-09-17       Impact factor: 6.876

5.  Temporal hemodynamic changes in a female mouse model of systemic lupus erythematosus.

Authors:  Elena L Dent; Erin B Taylor; Jennifer M Sasser; Michael J Ryan
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-09

6.  Serum cystatin C measured by a sol particle homogeneous immunoassay can accurately detect early impairment of renal function.

Authors:  Hiroe Sato; Junichiro J Kazama; Takeshi Kuroda; Ichiei Narita; Masaaki Nakano; Fumitake Gejyo
Journal:  Clin Exp Nephrol       Date:  2008-04-17       Impact factor: 2.801

7.  High frequency of nocturnal hypertension in lupus nephritis: should ABPM be implemented in usual practice?

Authors:  Juan M Mejia-Vilet; Yesser J López-Hernández; Mariedel Trujeque-Matos; J Iván Santander-Velez; Mayra L Cano-Verduzco; Cristino Cruz; Luis E Morales-Buenrostro
Journal:  Clin Rheumatol       Date:  2019-12-14       Impact factor: 2.980

Review 8.  The pathophysiology of hypertension in systemic lupus erythematosus.

Authors:  Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-01-21       Impact factor: 3.619

9.  Blood pressure and albuminuria in a female mouse model of systemic lupus erythematosus: impact of long-term high salt consumption.

Authors:  Elena L Dent; Hanna J Broome; Jennifer M Sasser; Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-08-19       Impact factor: 3.619

10.  Curcumin attenuates autoimmunity and renal injury in an experimental model of systemic lupus erythematosus.

Authors:  Elena L Dent; Erin B Taylor; Hannah R Turbeville; Michael J Ryan
Journal:  Physiol Rep       Date:  2020-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.